BIOFIRE FILMARRAY Gastrointestinal (GI) Panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with BIOFIRE FILMARRAY Systems.
Published January 17, 2024 · Recall initiated: November 27, 2023
Summary
FDA records medical device Class II recall Z-0703-2024, published January 17, 2024 and initiated November 27, 2023. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 53 Kits; Lot: UDI-DI: 00815381020109. Kit Lot/Pouch Lot/Expiration: 1749723/2XKB23/July 6, 2024; 1746223/2XJA23/July 6, 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification of an outbreak, and may result in additional transmission.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioFire Diagnostics, LLC
- Distributor
- US: NC, MO, NE, CT, IL, TN, NJ, OH, MA, CA, FL, UT, IA, KS, TX, MD
- Lot
- UDI-DI: 00815381020109. Kit Lot/Pouch Lot/Expiration: 1749723/2XKB23/July 6, 2024; 1746223/2XJA23/July 6, 2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGeneric Name: FilmArray® Pneumonia Panel Generic Name: FilmArray® Pneumonia Panel Model/Catalog Number:October 21, 2026
- FDAGeneric Name: FilmArray® Pneumonia Panel plus Generic Name: FilmArray® Pneumonia Panel plus Model/CatalogOctober 21, 2026
- FDAGeneric Name: BioFire® Joint Infection (JI) Panel Generic Name: BioFire® Joint Infection (JI) PanelOctober 21, 2026
- FDABIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acidAugust 19, 2026
- FDADetector H. Pylori, Catalog Number IHP-30January 17, 2024
- FDAThe BIOFIRE Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use withJanuary 17, 2024
Questions about this recall
Was BIOFIRE FILMARRAY Gastrointestinal (GI) Panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with BIOFIRE FILMARRAY Systems. recalled?
Yes. FDA published recall Z-0703-2024 on January 17, 2024. Reported hazard: A manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification of an outbreak, and may result in additional transmission.
What should I do if I have this product?
Voluntary: Firm initiated · Letter